Company intelligence / Profile preview

Chemspec-API

Fairfield, New Jersey, United Stateschemspec-api.com ↗

Ownership: Private
Development stage: Commercial

Overview

Chemspec-API is an FDA-inspected CMO/CDMO specializing in the development and manufacture of small molecule active pharmaceutical ingredients (APIs) and intermediates. The company supports process R&D through to commercial production under cGMP conditions. It has completed multiple FDA inspections since 2001, offers regulatory support, analytical services, methods validation, integrated R&D with its parent Shanghai Chemspec in China, and supplies both developmental/generic APIs as well as custom projects for clients.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Joint venture between Shanghai Chemspec Corp. and API Inc.Collaborations with APAC/Sinova/Acesys

Beyond the preview

Go deeper on Chemspec-API.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemspec-API.

Explore the full profile